Bain Capital Life Sciences: Bain Capital is one of the world’s leading alternative investment firms and manage approximately $160 billion in assets. Bain Capital Life Sciences invests in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies globally, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs.

The differentiated skillset of Bain Capital’s team enables it to pursue opportunities created by several longterm trends in healthcare. In particular, these trends are creating an increased need for targeted capital and value-added strategic support of companies around their critical phases of growth, during which they must prove their clinical and business value.